Catechol-O-Methyltransferase and Cytochrome P-450 1B1 Polymorphisms and Endometrial Cancer Risk A Meta-analysis

被引:14
|
作者
Teng, Yue [1 ]
He, Caiyun [2 ]
Zuo, Xiaohang [3 ]
Li, Xu [1 ]
机构
[1] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Ctr Translat Med, Xian 710061, Peoples R China
[2] China Med Univ, Key Lab Canc Control Liaoning Prov, Tumor Etiol & Screening Dept Canc Inst & Gen Surg, Affiliated Hosp 1, Shenyang, Peoples R China
[3] 323 Hosp Chinese Peoples Liberat Army, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
COMT; CYP1B1; Polymorphism; Endometrial cancer; Meta-analysis; CYP1B1 GENE POLYMORPHISMS; P4501B1; ALPHA; EXPRESSION; BETA;
D O I
10.1097/IGC.0b013e3182849e0d
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Disordered metabolism of estrogen is believed to play a significant role in endometrial carcinogenesis. Recently, a number of studies have been conducted to identify the role of estrogen-related gene polymorphism in endometrial cancer risk, generating conflicting conclusions. This meta-analysis aimed to assess the association between genetic polymorphisms involving estrogen metabolic enzymes and endometrial cancer risk. Methods: A systematic search of 6 databases was conducted. Fourteen studies on the association of COMT (catechol-O-methyltransferase) Val158Met, CYP1B1 Leu432Val, and CYP1B1 Asn453Ser polymorphisms with endometrial cancer risk were identified, enrolling a total of 4283 cancer cases and 7094 controls. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the relationship. Results: In CYP1B1 Leu432Val(rs1056836) analysis, the heterozygous genotype (CG) demonstrated an increased risk for endometrial cancer (Val/Leu vs Leu/Leu: pooled OR, 1.11; 95% CI, 1.01-1.23; P = 0.039; I-2 = 10.5%; (Val/Val + Val/Leu) vs Leu/Leu: pooled OR, 1.19; 95% CI, 1.03-1.38; P = 0.017; I-2 = 54.7%). As for CYP1B1 Asn453Ser(rs1800440) polymorphism, a decreased risk was observed in G allele compared with A allele (Ser vs Asn: pooled OR, 0.82; 95% CI, 0.72-0.94; P = 0.005; I-2 = 0.0%), and heterozygous genotype also showed a decreased risk compared with normal genotype (Ser/Asn vs Asn/Asn: pooled OR, 0.81; 95% CI, 0.69-0.95; P = 0.011; I-2 = 0.0%). As for COMT Val158Met (rs4680) polymorphism, the heterogeneous genotype showed a decreased risk for endometrial cancer compared with the common homogenous genotype in a fixed-effect model in Asian population (Met/Val vs Val/Val: pooled OR, 0.83; 95% CI, 0.70-0.98; P = 0.033; I-2 = 29.2%), whereas no positive results are found in other subgroups or models. Conclusions: COMT Val158Met was seen to show a decreased risk for endometrial cancer in Asian population. CYP1B1 Leu432Val and Asn453Ser polymorphisms demonstrated an increased and decreased risk for endometrial cancer, respectively. Further large and comprehensive studies in various populations with more detailed individual data are needed to confirm our findings.
引用
收藏
页码:422 / 430
页数:9
相关论文
共 50 条
  • [11] Cancer activation and polymorphisms of human cytochrome P450 1B1
    Chun Y.-J.
    Kim D.
    Toxicological Research, 2016, 32 (2) : 89 - 93
  • [12] Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk
    Saintot, M
    Malaveille, C
    Hautefeuille, A
    Gerber, M
    INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (04) : 652 - 657
  • [13] Differences of cytochrome P450 1B1 polymorphisms on prostate cancer risk between races
    Kato, Taku
    Hashimoto, Yutaka
    Wong, Ryan
    Mitsui, Yozo
    Maekawa, Shigekatsu
    Yamamura, Soichiro
    Majid, Shahana
    Saini, Sharanjot
    Shahryari, Varahram
    Tabatabai, Laura
    Shiina, Hiroaki
    Dahiya, Rajvir
    Deguchi, Takashi
    Tanaka, Yuichiro
    CANCER RESEARCH, 2018, 78 (13)
  • [14] Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk
    Skibola, CF
    Bracci, PM
    Paynter, RA
    Forrest, MS
    Agana, L
    Woodage, T
    Guegler, K
    Smith, MT
    Holly, EA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (10) : 2391 - 2401
  • [15] Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1
    Shimada, T
    Hayes, CL
    Yamazaki, H
    Amin, S
    Hecht, SS
    Guengerich, FP
    Sutter, TR
    CANCER RESEARCH, 1996, 56 (13) : 2979 - 2984
  • [16] Risk of cytochrome P450 1B1 missense polymorphisms in renal cell carcinoma
    Tanaka, Yuichiro
    Chang, Inik
    Majid, Shahana
    Saini, Sharanjot
    Zaman, Mohd S.
    Yamamura, Soichiro
    Chiyomaru, Takeshi
    Arora, Sumit
    Singh, Kamaldeep
    Shahryari, Varahram
    Dahiya, Angela V.
    Deng, Guoren
    CANCER RESEARCH, 2012, 72
  • [17] Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men
    Chang, Inik
    Fukuhara, Shinichiro
    Wong, Darryn K.
    Gill, Ankurpreet
    Mitsui, Yozo
    Majid, Shahana
    Saini, Sharanjot
    Yamamura, Soichiro
    Chiyomaru, Takeshi
    Hirata, Hiroshi
    Ueno, Koji
    Arora, Sumit
    Shahryari, Varahram
    Deng, Guoren
    Tabatabai, Z. Laura
    Greene, Kirsten L.
    Shin, Dong Min
    Enokida, Hideki
    Shiina, Hiroaki
    Nonomura, Norio
    Dahiya, Rajvir
    Tanaka, Yuichiro
    TUMOR BIOLOGY, 2014, 35 (10) : 10223 - 10230
  • [18] RISKS OF CYTOCHROME P450 1B1 POLYMORPHISMS AND LIFESTYLE CHOICES ON PROSTATE CANCER
    Kato, Taku
    Hashimoto, Yutaka
    Maekawa, Shigekatsu
    Shiina, Marisa
    Imai-Sumida, Mitsuho
    Dasgupta, Pritha
    Kulkarni, Priyanka
    Yamamura, Soichiro
    Majid, Shahana
    Saini, Sharanjot
    Sharryari, Varahram
    Deng, Guoren
    Dahiya, Rajvir
    Tanaka, Yuichiro
    JOURNAL OF UROLOGY, 2017, 197 (04): : E164 - E164
  • [19] Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis
    Lin, G.
    Zhao, J.
    Wu, J.
    Andreevich O, R.
    Zhang, W. -H.
    Zhang, Y.
    Yu, L.
    GENETICS AND MOLECULAR RESEARCH, 2013, 12 (04): : 6442 - 6453
  • [20] Cytochrome P450CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population
    Kocabas, NA
    Sardas, S
    Cholerton, S
    Daly, AK
    Karakaya, AE
    ARCHIVES OF TOXICOLOGY, 2002, 76 (11) : 643 - 649